Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martín Broto

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Oncology|December 17, 2018
Advancing towards Better Cooperation for Better Sarcoma PrognosesJavier Martín Broto
Oncology|April 13, 2021
Current Reality of Treating Advanced Soft Tissue Sarcoma as Illustrated by Case StudiesJavier Martín Broto, Robin L Jones
Future Oncology (London, England)|December 6, 2016
The importance of treating by histological subtype in advanced soft tissue sarcomaJavier Martín Broto, Axel Le Cesne, Peter Reichardt
Future Oncology (London, England)|October 6, 2022
Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomesGiovanni Grignani, Axel Le Cesne, Javier Martín-Broto
Future Oncology (London, England)|October 6, 2022
A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcomaAxel Le Cesne, Javier Martín-Broto, Giovanni Grignani
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2026
Reply to: Mifamurtide in Nonmetastatic High-Grade OsteosarcomaEmanuela Palmerini, Massimo Serra, Toni Ibrahim, et al.
Future Oncology (London, England)|June 5, 2015
Trabectedin clinical cases: use according to indication in diverse clinical scenariosGiovanni Grignani, Javier Martín-Broto, Markus Schuler, et al.
Expert Review of Anticancer Therapy|May 1, 2020
Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtypeJavier Martín-Broto, Peter Reichardt, Robin L Jones, et al.
Future Oncology (London, England)|May 3, 2017
Review of past and present clinical cases with a view to future treatment optionsJavier Martín-Broto, Peter Reichardt, Silvia Stacchiotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2020
Facts and Hopes in Immunotherapy of Soft-Tissue SarcomasJavier Martín-Broto, David S Moura, Brian A Van Tine
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Oncology|December 17, 2018
Advancing towards Better Cooperation for Better Sarcoma PrognosesJavier Martín Broto
Oncology|April 13, 2021
Current Reality of Treating Advanced Soft Tissue Sarcoma as Illustrated by Case StudiesJavier Martín Broto, Robin L Jones
Future Oncology (London, England)|December 6, 2016
The importance of treating by histological subtype in advanced soft tissue sarcomaJavier Martín Broto, Axel Le Cesne, Peter Reichardt
Future Oncology (London, England)|October 6, 2022
Trabectedin as second-line treatment in advanced soft tissue sarcoma: quality of life and safety outcomesGiovanni Grignani, Axel Le Cesne, Javier Martín-Broto
Future Oncology (London, England)|October 6, 2022
A review of the efficacy of trabectedin as second-line treatment of advanced soft tissue sarcomaAxel Le Cesne, Javier Martín-Broto, Giovanni Grignani
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2026
Reply to: Mifamurtide in Nonmetastatic High-Grade OsteosarcomaEmanuela Palmerini, Massimo Serra, Toni Ibrahim, et al.
Future Oncology (London, England)|June 5, 2015
Trabectedin clinical cases: use according to indication in diverse clinical scenariosGiovanni Grignani, Javier Martín-Broto, Markus Schuler, et al.
Expert Review of Anticancer Therapy|May 1, 2020
Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtypeJavier Martín-Broto, Peter Reichardt, Robin L Jones, et al.
Future Oncology (London, England)|May 3, 2017
Review of past and present clinical cases with a view to future treatment optionsJavier Martín-Broto, Peter Reichardt, Silvia Stacchiotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2020
Facts and Hopes in Immunotherapy of Soft-Tissue SarcomasJavier Martín-Broto, David S Moura, Brian A Van Tine
Pageof 7